Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

BioLine RX Ltd ADR

Start price
Target price
Perf. (%)
€1.64
30.09.23
€1.00
30.09.24
-9.76%
14.10.23

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
buy
Cellectis SA ADR

Start price
Target price
Perf. (%)
€2.32
07.10.22
€5.00
07.10.23
-43.97%
08.10.23

Could be worthwhile Investment >10% per year
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€2.12
27.09.23
-
27.09.24
-35.70%
30.09.23

Risky Investment
Ose Pharma International S.A.

Start price
Target price
Perf. (%)
€5.11
16.09.23
€2.00
16.09.24
-14.09%
30.09.23

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Pulse Biosciences Inc

Start price
Target price
Perf. (%)
€4.58
13.04.23
-
13.04.26
-14.85%
26.09.23

Risky Investment
BioLine RX Ltd ADR

Start price
Target price
Perf. (%)
€1.97
03.09.23
-
03.09.24
-21.32%
13.09.23

Risky Investment
BioLine RX Ltd ADR

Start price
Target price
Perf. (%)
€2.40
11.09.23
-
11.09.24
-22.50%
12.09.23

Probably not worthwhile Investment
buy
BioLine RX Ltd ADR

Start price
Target price
Perf. (%)
€1.97
03.09.23
€2.50
31.07.25
18.78%
06.09.23

Could be very worthwhile Investment >20% year
buy
HTG Molecular Diagnostics Inc.

Start price
Target price
Perf. (%)
€3.79
27.12.22
-
27.12.23
-90.75%
29.07.23

Capable Management
Risky Investment
No uniques
No Innovation
buy
PDS Biotechnology Corp.

Start price
Target price
Perf. (%)
€5.51
07.06.23
-
07.06.24
1.63%
09.06.23

Risky Investment
Immutep LTD ADR

Start price
Target price
Perf. (%)
€3.38
17.05.23
-
17.05.24
-39.65%
23.05.23

Could be very worthwhile Investment >20% year
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€3.14
26.12.22
-
26.12.23
238.02%
18.05.23

Could be very worthwhile Investment >20% year
buy
Kineta Inc.

Start price
Target price
Perf. (%)
€53.20
18.10.21
€84.00
31.12.23
-96.49%
08.05.23

Could be very worthwhile Investment >20% year
buy
PAVmed Inc

Start price
Target price
Perf. (%)
€7.20
08.10.21
€12.00
31.12.23
-94.39%
08.05.23

Could be very worthwhile Investment >20% year
buy
TRACON Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€3.62
27.09.21
€5.00
31.12.23
-11.60%
08.05.23

Could be very worthwhile Investment >20% year
buy
PDS Biotechnology Corp.

Start price
Target price
Perf. (%)
€12.54
18.09.21
€20.00
31.12.23
-52.05%
08.05.23

Could be very worthwhile Investment >20% year
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€7.15
09.09.21
€10.00
31.12.23
-75.78%
08.05.23

Could be very worthwhile Investment >20% year
buy
Celldex Therapeutics

Start price
Target price
Perf. (%)
€43.66
30.08.21
€110.00
31.12.23
-31.75%
08.05.23

Could be very worthwhile Investment >20% year
buy
Larimar Therapeutics Inc.

Start price
Target price
Perf. (%)
€11.70
30.08.21
€30.00
31.12.23
-63.93%
08.05.23

Could be very worthwhile Investment >20% year
buy
BioLase Inc.

Start price
Target price
Perf. (%)
€4.73
06.05.22
-
06.05.23
-96.11%
06.05.23

buy
Ose Pharma International S.A.

Start price
Target price
Perf. (%)
€7.32
04.05.22
€9.00
04.05.23
-49.42%
05.05.23

Could be worthwhile Investment >10% per year
buy
aTyr Pharma Inc

Start price
Target price
Perf. (%)
€2.30
06.02.23
€3.50
31.12.25
-16.01%
05.05.23

Could be very worthwhile Investment >20% year
buy
Cidara Therapeutics Inc

Start price
Target price
Perf. (%)
€1.43
06.02.23
€3.00
31.12.25
-35.87%
05.05.23

Could be very worthwhile Investment >20% year
buy
Larimar Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.18
20.09.22
€7.00
31.08.25
32.08%
05.05.23

Could be very worthwhile Investment >20% year
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€2.16
10.01.23
€4.00
31.12.25
-46.57%
05.05.23

Could be very worthwhile Investment >20% year